glp 1 agonist gastroparesis GLP-1 receptor agonists and delayed gastric emptying: implications for invasive cardiac interventions and surgery GLP-1 Gastroparesis: Hidden Dangers Beyond

Compared with other second- or third-line glucose-lowering medications, the GLP-1RAs demonstrated a lower rate of adverse CVEs, including heart failure (HR 0.88

Even more concerning

Originally developed to treat type 2 diabetes (T2D), these drugs have since delivered major advances in managing obesity and cardiovascular risk reduction

Discover how strategic nutrition, targeted supplements, and key lifestyle habits can naturally enhance GLP-1 activity to support appetite control, metabolic balance, and sustainable weight outcomes.

This supplement is designed for health-conscious adults looking to support their wellness goals alongside a balanced diet and regular exercise

The liver data may be even more important for employers